IMMUNYX PHARMA LTD
Professor Racah Blvd Givat Ram – Jerusalem – 9370641
VAT: IL516339264
nan
Complicit EU Projects
IMMUNYX PHARMA LTD did not participate in Horizon 2020 (2014-2020).
Within the Horizon Europe (2021-2027) framework, IMMUNYX PHARMA LTD has received € 252,656.0 for its participation in a total of 1 project(s) with a total cost of € 5,999,381.
Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
---|---|---|---|---|---|---|---|---|---|---|
2022-06-01 | 101057250 | CANCERNA | melanoma · vaccines · RNA · immunotherapy · leukemia | 2025-05-31 | participant | € 252,656.0 | € 5,999,381 | 6 | 13 | CORDIS ↪ |
IMMUNYX PHARMA LTD did not participate in FP7 (2007-2013).